Dr. Ian O'Brien Carter-O'Connell's lab at Santa Clara University focuses on understanding how a specific type of chemical modification in proteins, called ADP-ribosylation, works in cells. The research explores how this modification affects key biological processes, particularly in viruses and related diseases. The lab aims to create novel therapeutic approaches that can interrupt harmful viral activities by targeting the enzymes that process ADP-ribose, providing insights into mechanisms that could lead to new treatments.